These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 11123291)

  • 21. Signal transduction by the cytoplasmic domains of Fc epsilon RI-gamma and TCR-zeta in rat basophilic leukemia cells.
    Eiseman E; Bolen JB
    J Biol Chem; 1992 Oct; 267(29):21027-32. PubMed ID: 1383215
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Specific activation and targeting of cytotoxic lymphocytes through chimeric single chains consisting of antibody-binding domains and the gamma or zeta subunits of the immunoglobulin and T-cell receptors.
    Eshhar Z; Waks T; Gross G; Schindler DG
    Proc Natl Acad Sci U S A; 1993 Jan; 90(2):720-4. PubMed ID: 8421711
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Targeting of T lymphocytes to melanoma cells through chimeric anti-GD3 immunoglobulin T-cell receptors.
    Yun CO; Nolan KF; Beecham EJ; Reisfeld RA; Junghans RP
    Neoplasia; 2000; 2(5):449-59. PubMed ID: 11191112
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adoptive transfer of in vitro-targeted, activated T lymphocytes results in total tumor regression.
    Altenschmidt U; Klundt E; Groner B
    J Immunol; 1997 Dec; 159(11):5509-15. PubMed ID: 9548491
    [TBL] [Abstract][Full Text] [Related]  

  • 25. T cell receptor-independent CD2 signal transduction in FcR+ cells.
    Arulanandam AR; Koyasu S; Reinherz EL
    J Exp Med; 1991 Apr; 173(4):859-68. PubMed ID: 1706751
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Forced expression of the Fc receptor gamma-chain renders human T cells hyperresponsive to TCR/CD3 stimulation.
    Nambiar MP; Fisher CU; Kumar A; Tsokos CG; Warke VG; Tsokos GC
    J Immunol; 2003 Mar; 170(6):2871-6. PubMed ID: 12626537
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Generation and targeting of human tumor-specific Tc1 and Th1 cells transduced with a lentivirus containing a chimeric immunoglobulin T-cell receptor.
    Gyobu H; Tsuji T; Suzuki Y; Ohkuri T; Chamoto K; Kuroki M; Miyoshi H; Kawarada Y; Katoh H; Takeshima T; Nishimura T
    Cancer Res; 2004 Feb; 64(4):1490-5. PubMed ID: 14973062
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The high affinity Fc epsilon receptor gamma subunit (Fc epsilon RI gamma) facilitates T cell receptor expression and antigen/major histocompatibility complex-driven signaling in the absence of CD3 zeta and CD3 eta.
    Rodewald HR; Arulanandam AR; Koyasu S; Reinherz EL
    J Biol Chem; 1991 Aug; 266(24):15974-8. PubMed ID: 1714902
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recognition of human colon cancer by T cells transduced with a chimeric receptor gene.
    Daly T; Royal RE; Kershaw MH; Treisman J; Wang G; Li W; Herlyn D; Eshhar Z; Hwu P
    Cancer Gene Ther; 2000 Feb; 7(2):284-91. PubMed ID: 10770638
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tumor-specific T cell activation by recombinant immunoreceptors: CD3 zeta signaling and CD28 costimulation are simultaneously required for efficient IL-2 secretion and can be integrated into one combined CD28/CD3 zeta signaling receptor molecule.
    Hombach A; Wieczarkowiecz A; Marquardt T; Heuser C; Usai L; Pohl C; Seliger B; Abken H
    J Immunol; 2001 Dec; 167(11):6123-31. PubMed ID: 11714771
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Critical components of a DNA fusion vaccine able to induce protective cytotoxic T cells against a single epitope of a tumor antigen.
    Rice J; Buchan S; Stevenson FK
    J Immunol; 2002 Oct; 169(7):3908-13. PubMed ID: 12244189
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Specific lysis of melanoma cells by receptor grafted T cells is enhanced by anti-idiotypic monoclonal antibodies directed to the scFv domain of the receptor.
    Reinhold U; Liu L; Lüdtke-Handjery HC; Heuser C; Hombach A; Wang X; Tilgen W; Ferrone S; Abken H
    J Invest Dermatol; 1999 May; 112(5):744-50. PubMed ID: 10233766
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Agonist peptide from a cytotoxic t-lymphocyte epitope of human carcinoembryonic antigen stimulates production of tc1-type cytokines and increases tyrosine phosphorylation more efficiently than cognate peptide.
    Salazar E; Zaremba S; Arlen PM; Tsang KY; Schlom J
    Int J Cancer; 2000 Mar; 85(6):829-38. PubMed ID: 10709104
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Redirecting mouse T hybridoma against human breast and ovarian carcinomas: in vivo activity against HER-2/neu expressing cancer cells.
    Gritzapis AD; Mamalaki A; Kretsovali A; Papamatheakis J; Belimezi M; Perez SA; Baxevanis CN; Papamichail M
    Br J Cancer; 2003 Apr; 88(8):1292-300. PubMed ID: 12698199
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Redirecting therapeutic T cells against myelin-specific T lymphocytes using a humanized myelin basic protein-HLA-DR2-zeta chimeric receptor.
    Moisini I; Nguyen P; Fugger L; Geiger TL
    J Immunol; 2008 Mar; 180(5):3601-11. PubMed ID: 18292588
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tumor vessel-injuring ability improves antitumor effect of cytotoxic T lymphocytes in adoptive immunotherapy.
    Kanagawa N; Yanagawa T; Nakagawa T; Okada N; Nakagawa S
    Cancer Gene Ther; 2013 Jan; 20(1):57-64. PubMed ID: 23175243
    [TBL] [Abstract][Full Text] [Related]  

  • 37. T cell receptor complexes containing Fc epsilon RI gamma homodimers in lieu of CD3 zeta and CD3 eta components: a novel isoform expressed on large granular lymphocytes.
    Koyasu S; D'Adamio L; Arulanandam AR; Abraham S; Clayton LK; Reinherz EL
    J Exp Med; 1992 Jan; 175(1):203-9. PubMed ID: 1530959
    [TBL] [Abstract][Full Text] [Related]  

  • 38. T cell targeting of TAG72+ tumor cells by a chimeric receptor with antibody-like specificity for a carbohydrate epitope.
    Hombach A; Heuser C; Sircar R; Tillmann T; Diehl V; Kruis W; Pohl C; Abken H
    Gastroenterology; 1997 Oct; 113(4):1163-70. PubMed ID: 9322511
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adoptive transfer of chimeric FcepsilonRI gene-modified human T cells for cancer immunotherapy.
    Teng MW; Kershaw MH; Jackson JT; Smyth MJ; Darcy PK
    Hum Gene Ther; 2006 Nov; 17(11):1134-43. PubMed ID: 17052145
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of signal transducing T-cell receptor zeta molecules after adoptive immunotherapy in patients with gastric and colon cancer.
    Kono K; Ichihara F; Iizuka H; Sekikawa T; Matsumoto Y
    Int J Cancer; 1998 Oct; 78(3):301-5. PubMed ID: 9766562
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.